FDA's next-gen medtech surveillance bets heavily on unique device identifiers

April 24, 2013 by Arezu Sarvestani

The FDA envisions a modernized medical device postmarket surveillance system, in which the long-awaited Unique Device Identifier program plays a big role.

FDA with magnifying glass

The FDA laid out plans to revamp its postmarket surveillance of medical devices, and a large part of that has to do with finalizing and implementing a long-awaited Unique Device Identifier program to better track and monitor devices.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.


Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp